ANGIO-SEAL™ VIP - CLINICAL EVIDENCE
2

SIMPLE. PROVEN. FAST SEALING

Featured product: Angio-Seal™ VIP Vascular Closure Device

neutrals-100
true
References
References

​​​Angio-Seal™ VIP is

  • a bioa​​bsorbable implantable medical device1​
  • intended for use in closing and reducing the time to hemostasis of common femoral arterial punctures following arterial access procedures1
  • proven to be safe, effective, and support rapid closure of the femoral access site2
neutrals-100
ANGIO-SEAL™ VIP DEMONSTRATED HIGHER DEPLOYMENT SUCCESS RATES VS OTHER VCD​​
3
neutrals-100

  • ​Angio-Seal™ VIP demonstrates high deployment success rates3,4 in diagnostic and interventional settings.​

    • 100% deployment success rate with Angio-Seal™ VIP 6Fr for diagnostic procedures
    • 98.5% deployment success rate with Angio-Seal™ VIP 6Fr for interventional procedures​
neutrals-100
  • Angio-Seal™ VIP has demonstrated higher deployment success rate compared to other VCD5
neutrals-100
​​ANGIO-SEAL™ VIP DEMONSTRATED LOWER COMPLICATION RATES VS MANUAL COMPRESSION
3
  • Angio-Seal™ VIP provides safe, effective, and rapid closure of the femoral access site2
  • Angio-Seal™ VIP has been clinically proven to have significantly lower complication rates than Manual Compression after PCI6​
ANGIO-SEAL™ VIP REDUCES THE TIME TO HEMOSTASIS
3
  • Angio-Seal™ VIP is indicated for use in closing and reducing time to hemostasis at the common femoral arterial puncture site1
ANGIO-SEAL™ VIP REDUCES THE TIME TO AMBULATION
3
  • Angio-Seal™ VIP is indicated for use to allow patients to ambulate safely as soon as possible after sheath removal and device placement1
  • Angio-Seal™ VIP has clinically proven to reduce time to ambulation7​​
ANGIO-SEAL™ VIP SUPPORTS EARLY DISCHARGE & COST SAVING​​​
3
neutrals-100
  • Angio-Seal™ VIP is associated with a significantly shorter length of hospital stay compared to manual compression8
  • Compared to manual compression, Angio-Seal™ VIP could lead to cost savings9 after endovascular procedures, despite the additional costs of the VCD itself
neutrals-100
ANGIO-SEAL™ VIP IS SAFE TO USE IN ANTEGRADE AND RETROGRADE FEMORAL PUNCTURE<sup>10</sup>
3
neutrals-100
  • Angio-Seal™ VIP is a bioabsorbable implantable medical device intended for use in closing and reducing the time to hemostasis of common femoral arterial punctures following arterial access procedures.1 This includes both ANTEGRADE and RETROGRADE punctures.​​​​
ANGIO-SEAL™ VIP & ARTERIAL RESTICK
3
  • Before considering Angio-Seal™ VIP, a common femoral angiogram of the site is indicated1​
ANGIO-SEAL™ VIP & PATIENTS WITH PERIPHERAL VASCULAR DISEASE<sup>1</sup>
3
neutrals-100

  • If patients have clinically significant PVD, Angio-Seal™ VIP can be deployed safely:​​

    • in patients with arteries >5 mm diameter
    • where there is found to be no luminal narrowing of 40% or greater within 5 mm of the puncture site
neutrals-100
References
text
Angio-Seal™​ VIP Instruction for use.
text
Wong H.F. et al. Am J Neuroradiol. 2013; 34: 397-401.
text
Martin J.L. et al. Catheter Cardiovasc Interv. 2008 Jan 1;71(1):1-5.
text
Modi S. et al. Indian J Radiol Imaging. 2013;23(2):134-138.
text
Jones L.E. et al. Ann Vasc Surg. 2018 Aug;51:10-17.
text
Kreutz R.P. et al J Soc Cardiovasc Angiogr Interv. 2022 Jun 29;1(5).
text
Alshehri A.M. et al. Int J Angiol. 2015 Jun; 24(2): 133–136.
text
Veasey R.A. et al. International Journal of Clinical Practice 2008, 62(6), 912–918.
text
Goueffic Y. et al. Ann Vasc Surg. 2023 Jul;93:64-70
text
Chaudhuri A. et al. Eur J Vasc Endovasc Surg. 2014 Aug;48(2):220-5.
text
Ipema J. et al. CRIT LIMB ISCHEM 2023 March 2.
text
Tellez A.et al. EuroIntervention. 2010 Jan;5(6):731-6.
section-id
References
Featured products
3
default-carousel
Angio-Seal™ VIP
Vascular Closure Device
/content/terumo-europe-ia/en/interventional-systems/products/product-type/closure-devices/angio-seal-vip-vascular-closure-device